SAINT-PRIEST, France--(BUSINESS WIRE)--Regulatory News: Biom’up (Paris:BUP) (the "Company"), specializing in surgical hemostasis, has announced that the U.S. Food and Drug Administration (FDA) has ...
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the introduction of the Disposable Curved Applicator, which ...
Biom’up SA, specializing in surgical haemostasis, announced the first sales of its Hemoblast Bellows Laparoscopic Applicator in US market. The first kits have been shipped overseas from Saint-Priest ...
Biom’up, specializing in surgical hemostasis, has announced that the US Food and Drug Administration (FDA) has granted marketing approval for its Hemoblast Bellows Laparoscopic Applicator for all ...